Evidence map›Paper›PMID 35864304›Full record

ReviewAging clinical and experimental research2022

Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach.

Nicholas Fuggle, Nathalie Bere, Olivier Bruyère, Mario Manuel Rosa, María Concepción Prieto Yerro, Elaine Dennison, Fitnat Dincer, Cem Gabay, Ida K Haugen, Gabriel Herrero-Beaumont and 17 more

Open access · hybridAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Aging clinical and experimental research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Mediterranean diet and osteoarthritis: an update.Aging clinical and experimental research · 2024
    Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 19 institutions in 18 countries.

Nicholas FuggleMRC Lifecourse Epidemiology Centre, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.
Nathalie BereEuropean Medicines Agency, Amsterdam, The Netherlands.
Olivier BruyèreDivision of Public Health, Epidemiology and Health Economics, WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, University of Liège, Avenue Hippocrate 13, CHU B23, 4000, Liege, Belgium.
Mario Manuel RosaFaculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal.
María Concepción Prieto YerroAgencia Española de Medicamentos y Productos Sanitarios, Madrid, Spain.
Elaine DennisonMRC Lifecourse Epidemiology Centre, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK.
Fitnat DincerDepartment of Physical and Rehabilitation Medicine, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Cem GabayDivision of Rheumatology, University Hospital of Geneva, and Department of Pathology and Immunology, University of Geneva of Medicine, Geneva, Switzerland.
Ida K HaugenDivision of Rheumatology and Research, Diakonhjemmet Hospital, Oslo, Norway.
Gabriel Herrero-BeaumontHead of Rheumatology Department, Bone and Joint Research Unit, IIS-Fundación Jiménez Díaz UAM, 28040, Madrid, Spain.
Mickaël HiligsmannDepartment of Health Services Research, CAPHRI Care and Public Health Research Institute, Maastricht University, 6200 MD, Maastricht, The Netherlands.
Marc C HochbergDepartments of Medicine and Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, MD, USA.
Andrea LaslopScientific Office, Federal Office for Safety in Health Care, Vienna, Austria.
Radmila MatijevicFaculty of Medicine, University of Novi Sad, Novi Sad, Serbia.
Emmanuel MaheuRheumatology Department, Hospital Saint-Antoine, AP-HP, and Private Office, Paris, France.
Alberto MiglioreRheumatology Unit - San Pietro Fatebenefratelli Hospital, Rome, Italy.
Jean-Pierre PelletierOsteoarthritis Research Unit, University of Montreal Hospital Research Centre (CRCHUM) and Arthritis Division, University of Montreal Hospital Centre (CHUM), Montreal, Canada.
Régis Pierre RadermeckerDepartment of Diabetes, Nutrition and Metabolic Disorders, Clinical Pharmacology, University of Liège, CHU de Liège, Liège, Belgium.
François RannouService de Rééducation et de Réadaptation de l'Appareil Locomoteur et des Pathologies du Rachis, Hôpitaux Universitaires-Paris Centre, Groupe Hospitalier Cochin, Assistance Publique-Hôpitaux de Paris, Université de Paris, INSERM U1124, Paris, France.
Brigitte UebelhartDivision of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Daniel UebelhartDivision of Musculoskeletal, Internal Medicine and Oncological Rehabilitation, Leukerbad Clinic -Private Rehabilitation Clinic, 3954, Leukerbad, Switzerland.
Nicola VeroneseDepartment of Internal Medicine, Geriatrics Section, University of Palermo, Palermo, Italy.
Mila VlaskovskaMedical Faculty, Department of Pharmacology and Toxicology, Medical University Sofia, Sofia, Bulgaria.
René RizzoliDivision of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, University of Geneva, Geneva, Switzerland.
Ali MobasheriDivision of Public Health, Epidemiology and Health Economics, WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, University of Liège, Avenue Hippocrate 13, CHU B23, 4000, Liege, Belgium.
Cyrus CooperMRC Lifecourse Epidemiology Centre, University of Southampton, Tremona Road, Southampton, SO16 6YD, UK. cc@mrc.soton.ac.uk.ORCID http://orcid.org/0000-0003-3510-0709
Jean-Yves ReginsterDivision of Public Health, Epidemiology and Health Economics, WHO Collaborating Center for Public Health Aspects of Musculo-Skeletal Health and Ageing, University of Liège, Avenue Hippocrate 13, CHU B23, 4000, Liege, Belgium.
University of Liège · BEMRC Lifecourse Epidemiology Unit · GBUniversity of Geneva · CHAgencia Española de Medicamentos y Productos Sanitarios · ESAustrian Agency for Health and Food Safety · ATDiakonhjemmet Hospital · NOEuropean Medicines Agency · NLFatebenefratelli Hospital · ITHacettepe University · TRHospital Universitario Fundación Jiménez Díaz · ESInserm · FRMaastricht University · NLMedical University of Sofia · BGSorbonne Université · FRUniversité de Montréal · CAUniversity of Lisbon · PTUniversity of Maryland, Baltimore · USUniversity of Novi Sad · RSUniversity of Palermo · IT

Funding

Medical Research Council G0400491Medical Research Council MC_PC_21000Medical Research Council MC_PC_21001Medical Research Council MC_PC_21003Medical Research Council MC_PC_21022Medical Research Council MC_U147585827Medical Research Council MC_UP_A620_1014Medical Research Council MC_UP_A620_1015Medical Research Council MC_UU_12011/1Medical Research Council MC_UU_12011/2Versus Arthritis 19583
6 · The paper itself

Abstract

Hand osteoarthritis is the most common joint condition and is associated with significant morbidity. It is of paramount importance that patients are thoroughly assessed and examined when complaining of hand stiffness, pain, deformity or disability and that the patient's concerns and expectations are addressed by the healthcare professional. In 2019 the American College of Rheumatology and Arthritis Foundation (ACR/AF) produced guidelines which included recommendations for the treatment of hand osteoarthritis. An ESCEO expert working group (including patients) was convened and composed this paper with the aim to assess whether these guidelines were appropriate for the treatment of hand osteoarthritis therapy in Europe and whether they met with the ESCEO patient-centered approach. Indeed, patients are the key stakeholders in healthcare and eliciting the patient's preference is vital in the context of an individual consultation but also for informing research and policy-making. The patients involved in this working group emphasised the often-neglected area of aesthetic changes in hand osteoarthritis, importance of developing pharmacological therapies which can alleviate pain and disability and the need of the freedom to choose which approach (out of pharmacological, surgical or non-pharmacological) they wished to pursue. Following robust appraisal, it was recommended that the ACR/AF guidelines were suitable for a European context (as described within the body of the manuscript) and it was emphasised that patient preferences are key to the success of individual consultations, future research and future policy-making.

Indexed as

Osteoarthritis, KneeEuropeEvidence-Based MedicineHumansPatient-Centered CareReferral and ConsultationHandManagementOsteoarthritisPatient-centeredTreatment guideline

Identifiers

PMID35864304
PMCPMC9464159
OpenAlexW4286500069

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.